do you lose muscle on glp-1 Study finds receptor agonists target fat over for weight loss Hidden Risks of GLP-1 Inhibitors:

Exposing human islets for 24h to 1mM LC-FFA (oleate/palmitate 2:1) triggers -cell death, vacuole accumulation and a decrease in LAMP2 expression (93)

[DOI] [PubMed] [Google Scholar] 8.Glutathione as a biomarker in Parkinson's disease: associations with aging and disease severity

Both prescription medications have been shown to benefit blood sugar levels and body weight

Softer or liquid protein sources (yoghurt, smoothies, soups) may be easier to consume than denser options

Unlike bariatric surgery, GLP-1 therapy does not bypass intestinal absorptive surfaces

So the uncomfortable conclusion remains: we do not yet have the kind of human trial evidence that should be driving widespread clinical adoption for injury recovery